<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS One</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40408619</article-id><article-id pub-id-type="pmc">PMC12101856</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0323697</article-id><article-id pub-id-type="publisher-id">PONE-D-25-09375</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Computer and Information Sciences</subject><subj-group><subject>Artificial Intelligence</subject><subj-group><subject>Artificial Neural Networks</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Computational Biology</subject><subj-group><subject>Computational Neuroscience</subject><subj-group><subject>Artificial Neural Networks</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Computational Neuroscience</subject><subj-group><subject>Artificial Neural Networks</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Hormones</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Hormones</subject><subj-group><subject>Peptide Hormones</subject><subj-group><subject>Growth Hormone</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Immunologic Techniques</subject><subj-group><subject>Immunoassays</subject><subj-group><subject>Enzyme-Linked Immunoassays</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Mathematical and Statistical Techniques</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Multivariate Analysis</subject><subj-group><subject>Principal Component Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics</subject><subj-group><subject>Statistical Methods</subject><subj-group><subject>Multivariate Analysis</subject><subj-group><subject>Principal Component Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Hormones</subject><subj-group><subject>Sex Hormones</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Hormones</subject><subj-group><subject>Thyroid Hormones</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Chemometrics-aided surface-enhanced Raman spectrometric detection and quantification of GH and TE hormones in blood</article-title><alt-title alt-title-type="running-head">Chemometrics-aided SERS detection and quantification of GH and TE hormones in blood</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4096-2813</contrib-id><name><surname>Ondieki</surname><given-names>Annah M.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/software/">Software</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7445-1603</contrib-id><name><surname>Birech</surname><given-names>Zephania</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kaduki</surname><given-names>Kenneth A.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mwangi</surname><given-names>Peter W.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Juma</surname><given-names>Moses</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chege</surname><given-names>Boniface M.</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff004" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Laser Physics and Spectroscopy Research Group, Department of Physics, University of Nairobi, Nairobi, Kenya</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Medical Physiology, University of Nairobi, Nairobi, Kenya</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>UNESCO-UNISA Africa Chair in Nanoscience/Nanotechnology, College of Graduate Studies, University of South Africa (UNISA), Pretoria, South Africa</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>School of Health Sciences, Dedan Kimathi University of Technology, Dedan Kimathi, Kenya</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Tabish</surname><given-names>Tanveer A.</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Oxford, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>There are no financial interests or personal relationships that could have appeared to influence the work reported in this paper and potential competing interests don&#x02019;t exist.</p></fn><corresp id="cor001">* E-mail: <email>moraa94annah@gmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>20</volume><issue>5</issue><elocation-id>e0323697</elocation-id><history><date date-type="received"><day>23</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>13</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 Ondieki et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Ondieki et al</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0323697.pdf">
</self-uri><abstract><p>Growth hormone (GH) and testosterone (TE) levels in blood are crucial indicators of human health and performance in clean sports. Deviations from normal levels can signal serious health issues, such as fertility problems, cancer, or pituitary tumors. Existing detection methods for these hormones are often costly, time-consuming, and lack portability. In this study, we explored the potential of Surface-Enhanced Raman Spectroscopy (SERS) in distinguishing blood samples from Sprague Dawley (SD) rats injected with exogenous GH, TE and both hormones from those not injected. Then, used artificial neural network (ANN) models trained, and validated in predicting levels of these hormones in blood. Blood samples from SD rats injected with GH, TE, both hormones, and non-injected rats were analyzed using the SERS method upon 785&#x02009;nm laser excitation. The recorded Raman spectra from blood of GH and TE injected and non-injected rats displayed hormone-specific band intensity variations. Additionally, Principal Component Analysis (PCA) showed temporal changes in band intensities post-injection, suggesting hormone-induced biochemical alterations. In particular, Raman bands centered around 1378 cm&#x0207b;&#x000b9; for all groups, 658 cm&#x0207b;&#x000b9; for GH, and 798 cm&#x0207b;&#x000b9; for GH and TE displayed significant intensity variations. The ANN models, trained using PCA scores from blood samples with varied hormone concentrations, achieved high predictive accuracy with coefficients of determination (R&#x000b2;&#x02009;&#x0003e;&#x02009;87.71%) and low root mean square error (RMSE&#x02009;&#x0003c;&#x02009;0.6436). Elevated hormone levels were initially observed in injected rats, gradually declining over time, with results aligning closely to those obtained via ELISA kits. This work showed that the SERS method can provide rapid (~2 minutes), hormone-independent detection with minimal sample preparation. This approach demonstrated the SERS method&#x02019;s potential for rapid, reliable hormone detection and with customized calibration may be applied in sports doping control, clinical diagnostics, and broader biomedical research.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>Swedish International Development Cooperation Agency (SIDA) through the International Science Programme (ISP), Uppsala University</institution>
</funding-source><award-id>KEN:04</award-id><principal-award-recipient>
<name><surname>Kaduki</surname><given-names>Kenneth A.</given-names></name>
</principal-award-recipient></award-group><funding-statement>Swedish International Development Cooperation Agency (SIDA) through the International Science Programme (ISP), Uppsala University, KEN:04, Prof. Kenneth A. Kaduki.</funding-statement></funding-group><counts><fig-count count="8"/><table-count count="2"/><page-count count="15"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>The data is available in Github: <ext-link xlink:href="https://github.com/Moraa1714/Matlab-codes-and-data-on-hormone-quantification" ext-link-type="uri">https://github.com/Moraa1714/Matlab-codes-and-data-on-hormone-quantification</ext-link>.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>The data is available in Github: <ext-link xlink:href="https://github.com/Moraa1714/Matlab-codes-and-data-on-hormone-quantification" ext-link-type="uri">https://github.com/Moraa1714/Matlab-codes-and-data-on-hormone-quantification</ext-link>.</p></notes></front><body><sec id="sec001"><title>1. Introduction</title><p>Growth hormone (GH) and Testosterone (TE) hormones are essential for regulating numerous physiological functions (i.e., muscle growth, development and strength, bone density and sexual health) in humans [<xref rid="pone.0323697.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0323697.ref002" ref-type="bibr">2</xref>]. Imbalance of these hormones can suggest endocrine disorders (i.e., diabetes, thyroid diseases, etc.) and metabolic syndromes [<xref rid="pone.0323697.ref003" ref-type="bibr">3</xref>]. In addition, these hormones are widely abused in sports, either singly or simultaneously, as performance enhancers, often with little awareness of severe long-term side effects such as hypertension [<xref rid="pone.0323697.ref004" ref-type="bibr">4</xref>]. Thus detection and quantification of these hormones&#x02019; levels in blood is crucial for both medical and sports-related applications.</p><p>The primary methods currently used to measure these hormone levels in blood are currently based on immunoassays and mass spectrometry as described in [<xref rid="pone.0323697.ref005" ref-type="bibr">5</xref>]. Immunoassays, such as enzyme-linked immunosorbent assays (ELISA), utilize specific antibodies to detect and quantify hormones based on their binding affinity [<xref rid="pone.0323697.ref006" ref-type="bibr">6</xref>]. Mass spectrometry, on the other hand, identifies hormones by measuring the mass-to-charge ratio of ionized molecules and provides high sensitivity and specificity [<xref rid="pone.0323697.ref007" ref-type="bibr">7</xref>]. However, both immunoassays and mass spectrometry have certain limitations. Immunoassays can suffer from cross-reactivity and are typically time-consuming due to the need for sample preparation and the use of antibodies. Mass spectrometry, while highly accurate, is often costly and requires advanced equipment, as well as skilled operators. Consequently, there is a strong need for developing innovative approaches for hormone detection.</p><p>Surface Enhanced Raman spectroscopy (SERS), a Raman variant technique well-suited for analyzing the sample&#x02019;s molecular composition and structural changes quantitatively [<xref rid="pone.0323697.ref008" ref-type="bibr">8</xref>], overcomes most of the listed disadvantages. SERS This technique offers significant advantages in that it is a label-free, non-destructive technique that can provide real-time, in situ measurements of hormone levels with high sensitivity and specificity [<xref rid="pone.0323697.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0323697.ref010" ref-type="bibr">10</xref>]. Unlike immunoassays and mass spectrometry, SERS does not require antibodies or complex sample preparation [<xref rid="pone.0323697.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0323697.ref012" ref-type="bibr">12</xref>]. It also allows for the detection of multiple biomarkers simultaneously, which is advantageous in analyzing complex biological samples [<xref rid="pone.0323697.ref011" ref-type="bibr">11</xref>]. Furthermore, SERS can be easily integrated into portable devices for on-site, point-of-care applications, making it an attractive alternative for rapid, cost-effective hormone level monitoring in clinical and field settings [<xref rid="pone.0323697.ref005" ref-type="bibr">5</xref>]. Although SERS holds significant potential for label-free detection of bio-molecular changes, interpreting the complex spectral information from biological samples presents numerous challenges [<xref rid="pone.0323697.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0323697.ref014" ref-type="bibr">14</xref>]. For instance, its quantification procedure is cumbersome as SERS intensity is influenced by not only concentration but also instrumental effects such as spatial resolution and detector sensitivity [<xref rid="pone.0323697.ref013" ref-type="bibr">13</xref>]. Thus, quantifying chemicals, molecules, or substances using SERS spectral data is often difficult unless chemometric techniques like principal component analysis (PCA) and artificial neural networks (ANNs) are employed [<xref rid="pone.0323697.ref015" ref-type="bibr">15</xref>&#x02013;<xref rid="pone.0323697.ref017" ref-type="bibr">17</xref>].</p><p>SERS combined with chemometrics has thus shown potential in biomedical fields in which hormone analysis such as estrogen [<xref rid="pone.0323697.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0323697.ref018" ref-type="bibr">18</xref>], disease diagnosis such as cancer [<xref rid="pone.0323697.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0323697.ref020" ref-type="bibr">20</xref>], and drug discovery [<xref rid="pone.0323697.ref021" ref-type="bibr">21</xref>] has been achieved. In addition, since this technique provides quick and nondestructive measurements for biological sample examination [<xref rid="pone.0323697.ref012" ref-type="bibr">12</xref>], it is very promising for a variety of in-lab and on-site applications such as sport doping detection [<xref rid="pone.0323697.ref022" ref-type="bibr">22</xref>]. In detection of sport dopants, this technique overcomes most of the demerits faced by conventional techniques such as enzyme-linked immunoassay (ELISA) [<xref rid="pone.0323697.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0323697.ref023" ref-type="bibr">23</xref>] and chromatographic methods [<xref rid="pone.0323697.ref024" ref-type="bibr">24</xref>]. Therefore, there is a great need to develop novel methods for singular or multiple detection of these dopants. In this work, SERS technique combined with ANN has been utilized for the detection of GH and TE hormones in blood from Sprague Dawley (SD) male rats.</p></sec><sec id="sec002"><title>2. Materials and methods</title><sec id="sec003"><title>2.1. Animal handling and blood sampling</title><p>Twenty-four SD rats, fed and kept as described in [<xref rid="pone.0323697.ref005" ref-type="bibr">5</xref>], were divided into four groups: Non-injected rats, GH-injected rats, TE-injected rats, and rats injected with both GH and TE, with each group containing six rats. The rats received intramuscular injections of GH and TE either individually or simultaneously once a day, based on their weight. The rats underwent euthanasia following an overnight fasting period, achieved through intraperitoneal administration of 6% Phenobarbital on week and all efforts were made to minimize suffering. Subsequently, blood samples were obtained from each rat&#x02019;s orbital sinus at six time points: before injection, and at 30 minutes, 2 hours, 4 hours, 8 hours, and 24 hours after administration. This was to help in determining how long these hormones get elevated in blood before they go back to their normal concentrations. All experimental procedures complied with the FELASA guidelines on the use and care of laboratory animals. This study was ethically approved by Biosafety, Animal Use and Ethics Committee of Faculty of Veterinary Medicine, University of Nairobi under reference number &#x0201c;FVM BAUEC/2023/539&#x0201d;</p></sec><sec id="sec004"><title>2.2. SERS measurements</title><p>Thirty microliters of each of the blood samples obtained were mixed thoroughly with 150 &#x000b5;l of AgNPs (fabricated by laser ablation in liquids) with 34&#x02009;nm diameter and spherical in shape as determined by SEM in [<xref rid="pone.0323697.ref025" ref-type="bibr">25</xref>]. Two microliters of the resulting mixture was then dropped onto aluminum-wrapped microscope glass slides (25.4 mm&#x02009;&#x000d7;&#x02009;76.2 mm&#x02009;&#x000d7;&#x02009;1.2&#x02009;mm dimensions) and left to dry in air at room temperature for sixty (60) minutes. The SERS (Raman) measurements were performed on each sample as described in [<xref rid="pone.0323697.ref005" ref-type="bibr">5</xref>] using a portable Raman spectrometer (EZRaman-N Portable Analyzer System, Enwave Optronics, USA) with 150 mW laser excitation power.</p></sec><sec id="sec005"><title>2.3. ANN model development and validation methods</title><p>Two ANN models were trained and validated based on the six PC scores (explaining about 90% of the data variability) of simulate samples (blood with different concentrations of GH and TE ranging from 0.01&#x02009;ng/ml to 60&#x02009;ng/ml) obtained from the PCA process as described in [<xref rid="pone.0323697.ref005" ref-type="bibr">5</xref>]. To ensure robust training and validation, a k-fold cross-validation strategy was employed. The samples used were about 30 different concentrations (each having 30 spectra total to approximately 900 spectra) with 75% forming the training set and 25% making the test set. The input layer of these two models was PC scores and the output was predicted concentration. The hidden layer was made of 5 layers (arranged as 12:10:10:10:6 (for GH model) and 10: 8: 8: 8:6 (for TE model)) with rectifier (ReLU) activation function and resilient backpropagation (rprop+) algorithm. These model architectures were determined through experimentation, using empirical testing and optimization to balance accuracy and efficiency. The distinct architectures likely address the unique data complexity, variability, and performance requirements of each hormone model, improving the overall model performance and reproducibility. The six PC scores (capture approximately 90% of the data variability) were used rather than the full spectral data because these reduced the model&#x02019;s input dimensionality, leading to more efficient computation and potentially faster training without sacrificing significant information, as the six components explain the majority of the variance in the data.</p><p>The test for the accuracy of these models was done using the validation metrics such as Root Mean Squared Error (RMSE), and coefficient of determination (R<sup>2</sup>) determined as shown in Equations (1) and (2) respectively.</p><disp-formula id="pone.0323697.e001">
<alternatives><graphic xlink:href="pone.0323697.e001.jpg" id="pone.0323697.e001g" position="anchor"/><mml:math id="M1" display="block" overflow="scroll"><mml:mrow><mml:mi>R</mml:mi><mml:mi>M</mml:mi><mml:mi>S</mml:mi><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:msqrt><mml:mrow/></mml:msqrt><mml:mo stretchy="false">(</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:mfrac><mml:msubsup><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives>
<label>(1)</label>
</disp-formula><disp-formula id="pone.0323697.e002">
<alternatives><graphic xlink:href="pone.0323697.e002.jpg" id="pone.0323697.e002g" position="anchor"/><mml:math id="M2" display="block" overflow="scroll"><mml:mrow><mml:msup><mml:mi>R</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:msubsup><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mo accent="true">&#x02015;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives>
<label>(2)</label>
</disp-formula><p>In which <inline-formula id="pone.0323697.e003"><alternatives><graphic xlink:href="pone.0323697.e003.jpg" id="pone.0323697.e003g" position="anchor"/><mml:math id="M3" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> represents the value of the predicted concentration, <inline-formula id="pone.0323697.e004"><alternatives><graphic xlink:href="pone.0323697.e004.jpg" id="pone.0323697.e004g" position="anchor"/><mml:math id="M4" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> the known concentration value, N the total number of samples, <inline-formula id="pone.0323697.e005"><alternatives><graphic xlink:href="pone.0323697.e005.jpg" id="pone.0323697.e005g" position="anchor"/><mml:math id="M5" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mo accent="true">&#x02015;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> represents the average value of the known concentration. The detection limits, specifically the limit of detection (LOD) and limit of quantification (LOQ), were also evaluated. The LOD was determined using Equation (3) (for minimum LOD) and Equation (4) (for maximum LOD) [<xref rid="pone.0323697.ref026" ref-type="bibr">26</xref>].</p><disp-formula id="pone.0323697.e006">
<alternatives><graphic xlink:href="pone.0323697.e006.jpg" id="pone.0323697.e006g" position="anchor"/><mml:math id="M6" display="block" overflow="scroll"><mml:mrow><mml:mtable columnspacing="" displaystyle="true" rowspacing="3pt"><mml:mtr><mml:mtd columnalign="right"><mml:msub><mml:mrow><mml:mi>L</mml:mi><mml:mi>O</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>3.3</mml:mn><mml:mi>&#x000d7;</mml:mi><mml:mi>[</mml:mi><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mi>y</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mi>]</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives>
<label>(3)</label>
</disp-formula><disp-formula id="pone.0323697.e007">
<alternatives><graphic xlink:href="pone.0323697.e007.jpg" id="pone.0323697.e007g" position="anchor"/><mml:math id="M7" display="block" overflow="scroll"><mml:mrow><mml:mtable columnspacing="" displaystyle="true" rowspacing="3pt"><mml:mtr><mml:mtd columnalign="right"><mml:msub><mml:mrow><mml:mi>L</mml:mi><mml:mi>O</mml:mi><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>3.3</mml:mn><mml:mi>&#x000d7;</mml:mi><mml:mi>[</mml:mi><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mi>&#x000d7;</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mi>&#x000d7;</mml:mi><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mi>y</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mi>]</mml:mi></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives>
<label>(4)</label>
</disp-formula><p>In which <inline-formula id="pone.0323697.e008"><alternatives><graphic xlink:href="pone.0323697.e008.jpg" id="pone.0323697.e008g" position="anchor"/><mml:math id="M8" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mrow><mml:mi>b</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> represents the standard deviation of the response (SERS spectra of male rat&#x02019;s blood), <inline-formula id="pone.0323697.e009"><alternatives><graphic xlink:href="pone.0323697.e009.jpg" id="pone.0323697.e009g" position="anchor"/><mml:math id="M9" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> represents the sensitivity of the calibration sample with minimum analyte concentration, <inline-formula id="pone.0323697.e010"><alternatives><graphic xlink:href="pone.0323697.e010.jpg" id="pone.0323697.e010g" position="anchor"/><mml:math id="M10" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>&#x003c3;</mml:mi><mml:mrow><mml:mi>y</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> is the standard deviation of calibration errors (residues), and <inline-formula id="pone.0323697.e011"><alternatives><graphic xlink:href="pone.0323697.e011.jpg" id="pone.0323697.e011g" position="anchor"/><mml:math id="M11" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>m</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> and <inline-formula id="pone.0323697.e012"><alternatives><graphic xlink:href="pone.0323697.e012.jpg" id="pone.0323697.e012g" position="anchor"/><mml:math id="M12" display="inline" overflow="scroll"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></alternatives></inline-formula> are the minimum and maximum blank leverages. The value 3.3 is the expansion factors obtained assuming a 95% confidence interval. The minimum and maximum LOQ were calculated using the two respective equations (Eqs. 3 and 4) by replacing the value 3.3 with 10 [<xref rid="pone.0323697.ref027" ref-type="bibr">27</xref>,<xref rid="pone.0323697.ref028" ref-type="bibr">28</xref>]. Low values of minimum detection limits suggested good model performance. ANN was used in this study because it models complex, nonlinear relationships and adapts to variable data distributions without predefined forms when compared to other curve-fitting methods. It can also efficiently handle high-dimensional inputs, generalize well on large datasets, and are more robust to noise, while curve-fitting methods may struggle with these challenges and require simpler model assumption. On ensuring that the models were accurate, the models were then used to predict the concentrations of these hormones (GH and TE) in blood from rats not injected and those injected with GH only, TE only, and both GH and TE. All these was done in MATLAB R2021a environment (version 9.10.0.1602886, The MathWorks Inc., Natick, USA).</p></sec></sec><sec id="sec006"><title>3. Results and discussions</title><sec id="sec007"><title>3.1. Qualitative analysis of blood from injected and non-injected rats</title><p>To identify the Raman intensity bands associated with GH, TE and both hormones (GH and TE) in blood of SD rats, the normalized and averaged SERS spectra (derived from thirty spectra per group) for blood from SD rats injected with GH only, TE only, both hormones and non-injected rats is displayed in <xref rid="pone.0323697.g001" ref-type="fig">Fig 1</xref>.</p><fig position="float" id="pone.0323697.g001"><object-id pub-id-type="doi">10.1371/journal.pone.0323697.g001</object-id><label>Fig 1</label><caption><title>SERS spectra for blood from rats injected with GH only, TE only, both GH and TE hormones, and non-injected rats.</title></caption><graphic xlink:href="pone.0323697.g001" position="float"/></fig><p>The SERS spectra of blood from non-injected and injected rats, as shown in <xref rid="pone.0323697.g001" ref-type="fig">Fig 1</xref>, appear nearly identical, with only slight variations in band intensity. These minor differences suggest subtle yet distinct biochemical changes resulting from hormone injections [<xref rid="pone.0323697.ref029" ref-type="bibr">29</xref>]. Rather than causing significant alterations in molecular composition, GH and TE injections likely influence specific biochemical pathways, leading to these variations. Such changes may involve slight modifications in protein conformation, lipid interactions, or hormone-related molecular rearrangements, which remain detectable through SERS despite the overall spectral similarity. The prominent bands noted were those centered around wavenumbers 658, 798, 878, 914, 932, 1064, 1190, 1354, 1410, and 1658&#x02009;cm<sup>-1</sup>. These bands were found to be related to those obtained from blood, and blood mixed with various concentrations of these hormones [<xref rid="pone.0323697.ref005" ref-type="bibr">5</xref>]. The bands centered around 600&#x02013;1064&#x02009;cm<sup>-1</sup> were assigned to C-C stretching [<xref rid="pone.0323697.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0323697.ref030" ref-type="bibr">30</xref>&#x02013;<xref rid="pone.0323697.ref032" ref-type="bibr">32</xref>], 1190&#x02009;cm<sup>-1</sup> assigned to C-O Stretch and COH bending [<xref rid="pone.0323697.ref033" ref-type="bibr">33</xref>], 1354&#x02009;cm<sup>-1</sup> assigned to Stretch (COO-) and C-H bend [<xref rid="pone.0323697.ref030" ref-type="bibr">30</xref>], and 1658&#x02009;cm<sup>-1</sup> assigned to C-O/C&#x02009;=&#x02009;O Stretching [<xref rid="pone.0323697.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0323697.ref010" ref-type="bibr">10</xref>]. The SERS bands with the highest intensity were those centered at around 658, 798, 932, and 1658&#x02009;cm<sup>-1</sup> for blood from rats injected with TE only; 878 and 914&#x02009;cm<sup>-1</sup> for blood from rats injected with both hormones; and 1354 and 1410&#x02009;cm<sup>-1</sup> for blood from rats injected with GH only. This analysis underscores the sensitivity of SERS in detecting hormonal influences on blood composition, providing a valuable tool for studying the biochemical effects of hormone treatments.</p><p>PCA was used to further investigate if there were differences in spectral patterns of the blood from non-injected rats and those injected with each of the two hormones. <xref rid="pone.0323697.g002" ref-type="fig">Fig 2</xref> shows the PCA scores and loadings plots for blood from GH-injected rats, TE-injected rats, and non-injected rats. The displayed score plots show clear segregation of the SERS spectral data sets for blood from GH-injected rats, TE-injected rats, and non-injected rats thus supporting the idea that the SERS spectroscopic technique is a potentially sensitive alternative hormonal assaying method (see <xref rid="pone.0323697.g002" ref-type="fig">Fig 2a</xref>). The three PCs explained 81.5% of the variability of the data, where PC1, PC2, and PC3 accounted for 43.2%, 23.2%, and 15.1% respectively. The SERS bands that brought about this segregation were determined using PCA loadings plot based on the PCA score segregation (see Fig 2b (i&#x02013;iii)). These bands are those centered at wavenumbers 684, 1042, 1378, and 1596&#x02009;cm<sup>-1</sup> for GH-injected rats (see <xref rid="pone.0323697.g002" ref-type="fig">Fig 2b</xref> (iv)); 798, 912, and 1690&#x02009;cm<sup>-1</sup> for TE-injected rats (see <xref rid="pone.0323697.g002" ref-type="fig">Fig 2b</xref> (v)); and 1206, 1456 and 1722&#x02009;cm<sup>-1</sup> for non-injected rats (see <xref rid="pone.0323697.g002" ref-type="fig">Fig 2b</xref> (vi)). Some of these bands matched exactly with some bands identified as concentration sensitive bands using simulate samples as shown by [<xref rid="pone.0323697.ref005" ref-type="bibr">5</xref>].</p><fig position="float" id="pone.0323697.g002"><object-id pub-id-type="doi">10.1371/journal.pone.0323697.g002</object-id><label>Fig 2</label><caption><title>Three-dimensional PCA (a) score plots, (b) loadings plot for (i) PC1, (ii) PC2, and (iii) PC3 loadings plot, and averaged SERS spectra of blood from (iv) rats injected with GH only, (v) rats injected with TE only and (vi) non-injected rats.</title><p>The explained variances are indicated in percentages and were 43.2%, 23.2%, and 15.1% for PC1, PC2, and PC3 respectively.</p></caption><graphic xlink:href="pone.0323697.g002" position="float"/></fig><p>To check whether there was spectral variation for different times before and after hormone injection, the average SERS spectra for each of the groups was plotted for different times - before injection and 0.5, 2, 4, 8, and 24 hours after injection as shown in <xref rid="pone.0323697.g003" ref-type="fig">Fig 3</xref>. From <xref rid="pone.0323697.g003" ref-type="fig">Fig 3</xref>, it is seen that the spectral profiles are very similar in each of the hormones for different times before and after injection. This likely means that some molecular constituents or metabolic pathways have relatively stable spectral signatures against the background of dynamic metabolic processes in response to hormone injection. Although the SERS spectral profiles obtained were generally very similar, subtle variations in SERS band intensities at specific wavenumbers of different times of the day and hormone groups are apparent. Noticeably, bands centered at 1350 and 1410&#x02009;cm<sup>-1</sup> show apparent differences related to non-injected rats, GH-injected rats, and TE-injected rats. Also, the band at 798&#x02009;cm<sup>-1</sup> has some variation, specifically with the GH injection. This may be an indication of the fact that these variations in metabolic responses of the hormone-specific molecular rearrangements within the tissue microenvironment mean an elevation of these hormones after an injection. To validate the observed differences, statistical analysis, including descriptive statistics and one-way ANOVA, was conducted. The results yielded standard deviations of 0.05362 (for 1350 cm&#x0207b;&#x000b9;), 0.04208 (for 1410 cm&#x0207b;&#x000b9;), and 0.06452 (for 798 cm&#x0207b;&#x000b9;), with variance values ranging between 0.003 and 0.004 for the three bands. These standard deviation and variance values indicate significant molecular response variations, potentially supporting the hypothesis that GH and TE injections induce molecular rearrangements detectable through spectroscopy.</p><fig position="float" id="pone.0323697.g003"><object-id pub-id-type="doi">10.1371/journal.pone.0323697.g003</object-id><label>Fig 3</label><caption><title>SERS spectra of different for blood from (a) non-injected rats, (b) rats injected with GH only, (c) rats injected with TE only, and (d) rats injected with both GH and TE hormones.</title><p>The blood was drawn at different times before and after injection.</p></caption><graphic xlink:href="pone.0323697.g003" position="float"/></fig><p>To determine further if there was spectral variation for different times before and after hormone injection, PCA was performed for each group for each at different times (before injection and 0.5, 2, 4, 8, and 24 hours after injection) (see <xref rid="pone.0323697.g004" ref-type="fig">Fig 4</xref>). As displayed in <xref rid="pone.0323697.g004" ref-type="fig">Fig 4</xref>, the first three PCs explained 82% (GH injected rats), 81.1% (TE injected rats), 76.8% (GH&#x02009;+&#x02009;TE injected rats), and 69.5% (non-injected rats) of the variance suggesting that the spectral profiles of blood obtained at different times were different. GH-injected rats had the highest variance, closely followed by TE-injected rats, while variance reduced in rats injected simultaneously with both hormones when compared to those injected singly. Non-injected rats exhibited the least variance, indicating more consistent spectral profiles.</p><fig position="float" id="pone.0323697.g004"><object-id pub-id-type="doi">10.1371/journal.pone.0323697.g004</object-id><label>Fig 4</label><caption><title>Three-dimensional PCA score plots for (a) rats injected with GH only, (b) Normal rats, (c) rats injected with TE only, and (d) rats injected simultaneously with GH and TE based on different times before and after injection.</title></caption><graphic xlink:href="pone.0323697.g004" position="float"/></fig><p>The loadings plot displayed in <xref rid="pone.0323697.g005" ref-type="fig">Fig 5</xref> shows that the bands responsible for the segregation of the data sets in the score plots were centered at around 1378&#x02009;cm<sup>-1</sup> (for all groups); 658&#x02009;cm<sup>-1</sup>, 1614&#x02009;cm<sup>-1</sup> (for GH injected rats), 798&#x02009;cm<sup>-1</sup> (separately GH and TE injected rats); 786&#x02009;cm<sup>-1</sup> (non-injected rats and rats injected with both GH and TE); 914 and 1240&#x02009;cm<sup>-1</sup> (TE injected rats and rats injected both GH and TE); 876 and 1636 cm-1 (rats injected both GH and TE). These bands could be used as Raman biomarker bands for periodic concentration (level) changes in blood for the respective hormones. These results also point to the great power of the SERS method in detecting subtle respective hormone level changes in blood.</p><fig position="float" id="pone.0323697.g005"><object-id pub-id-type="doi">10.1371/journal.pone.0323697.g005</object-id><label>Fig 5</label><caption><title>PCA loading plots and SERS Spectra of blood from rats injected with (a) GH only, (b) non-injected rats, (c) rats injected with TE only, and (d) rats injected simultaneously with GH and TE hormones drawn at different times before and after injection.</title></caption><graphic xlink:href="pone.0323697.g005" position="float"/></fig></sec><sec id="sec008"><title>3.2. Quantitative analysis of GH and TE hormones</title><p>Blood is a complex matrix composed of a myriad number of Raman active biological molecules with isoenergetic vibrational bands. In order to quantify the levels of the hormones of interest in this work, GH and TE, in blood multivariate analytical methods are necessary. In this work, artificial neural network (ANN) were employed in performing concentration determination in the investigated blood samples. Two ANN models (one for TE and the other for GH) were trained, validated and used to predict each hormone&#x02019;s concentration in blood. <xref rid="pone.0323697.t001" ref-type="table">Table 1</xref> displays validation results obtained from these developed ANN models.</p><table-wrap position="float" id="pone.0323697.t001"><object-id pub-id-type="doi">10.1371/journal.pone.0323697.t001</object-id><label>Table 1</label><caption><title>Validation metrics of the ANN models constructed, trained and validated.</title></caption><alternatives><graphic xlink:href="pone.0323697.t001" id="pone.0323697.t001g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Model</th><th align="left" colspan="2" rowspan="1">RMSE (ng/ml)</th><th align="left" colspan="2" rowspan="1">R<sup>2</sup></th></tr><tr><th align="left" rowspan="1" colspan="1">Training</th><th align="left" rowspan="1" colspan="1">Validation</th><th align="left" rowspan="1" colspan="1">Training</th><th align="left" rowspan="1" colspan="1">Validation</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Growth hormone</td><td align="left" rowspan="1" colspan="1">0.54489</td><td align="left" rowspan="1" colspan="1">0.64364</td><td align="left" rowspan="1" colspan="1">0.9135</td><td align="left" rowspan="1" colspan="1">0.8771</td></tr><tr><td align="left" rowspan="1" colspan="1">Testosterone</td><td align="left" rowspan="1" colspan="1">0.23870</td><td align="left" rowspan="1" colspan="1">0.42386</td><td align="left" rowspan="1" colspan="1">0.9804</td><td align="left" rowspan="1" colspan="1">0.9331</td></tr></tbody></table></alternatives></table-wrap><p>The success of the model is normally assessed by the high (low) values of the coefficient of determination, R<sup>2</sup> (low values of the root-mean square error, RMSE). Indeed, as seen from <xref rid="pone.0323697.t001" ref-type="table">Table 1</xref>, the RMSE values were low and the R<sup>2</sup> values were close to one which was an indication that these models were suitable for performing level predictions of these hormones in blood using the SERS data sets. Further performance evaluation of the models were assessed using the regression plots of predicted concentration versus the known (see <xref rid="pone.0323697.g006" ref-type="fig">Fig 6</xref>). In all models, data were close to the regression lines revealing that the predicted concentration of both the training and testing set was in acceptable good agreement with the experimental (actual) concentration. This confirmed the excellent performance of the models.</p><fig position="float" id="pone.0323697.g006"><object-id pub-id-type="doi">10.1371/journal.pone.0323697.g006</object-id><label>Fig 6</label><caption><title>ANN models&#x02019; regression curves showing predicted concentration against actual concentration.</title></caption><graphic xlink:href="pone.0323697.g006" position="float"/></fig><p>Using Equations 3 and 4 evaluated were also the detection limits, i.e., LOD and LOQ of the SERS method used in our work (see <xref rid="pone.0323697.t002" ref-type="table">Table 2</xref>). The minimum LOD deduced were 0.3222&#x02009;ng/ml (for GH) and 0.1851&#x02009;ng/ml (for TE) while the minimum LOQ determined were 0.9766&#x02009;ng/ml (for GH) and 0.5611&#x02009;ng/ml (for TE). This revealed that the LOD and LOQ values obtained for TE enanthate were notably in range with those reported by other analytical methods, as evidenced by the comparative data presented in <xref rid="pone.0323697.t002" ref-type="table">Table 2</xref>. For instance, from previous studies done on detection of TE using dried blood samples, the LOD obtained ranged from 0.05 to 0.2&#x02009;ng/ml when using NanoLC-HRMS/MS technique depending on the type of TE injected intramuscularly [<xref rid="pone.0323697.ref034" ref-type="bibr">34</xref>]. Similarly, a LOD of 0.2&#x02009;ng/ml and a LOQ of 0.5&#x02009;ng/ml for TE enanthate was obtained when using dried blood samples extraction coupled with TurboFlow technology and LC-HRMS by means of the DBSA-TLXHRMS system [<xref rid="pone.0323697.ref035" ref-type="bibr">35</xref>]. This implies that the SERS method combined with ANN models offers superior sensitivity in detecting and quantifying TE enanthate, thereby enhancing the precision and reliability of measurements in related research and clinical applications. When using GH ELISA assays the LOD and LOQ obtained were 0.04 and 0.065&#x02009;ng/ml respectively [<xref rid="pone.0323697.ref028" ref-type="bibr">28</xref>,<xref rid="pone.0323697.ref036" ref-type="bibr">36</xref>], while using isotope dilution mass spectrometry (IDMS) the values were 0.5&#x02009;ng/ml (LOD) and 0.7&#x02009;ng/ml (LOQ) [<xref rid="pone.0323697.ref037" ref-type="bibr">37</xref>]. Although the GH minimum detection limits obtained in this study are seen to be higher when compared to ELISA and lower when compared to IDMS (<xref rid="pone.0323697.t002" ref-type="table">Table 2</xref>) these values (LOD and LOQ) may still be acceptable since they are very low when compared with the range of GH concentrations typically encountered in the rat blood samples (3&#x02013;25&#x02009;ng/ml). Upon ascertaining that these models were accurate and had acceptable detection limits, they were used to detect the levels GH and TE hormones in blood of rats injected singly and simultaneously with the two hormones in comparison to those not injected. This is because elevation in concentrations of these hormones in blood above the normal or known concentrations might suggest doping which is often done by athletes to increase their sport activity [<xref rid="pone.0323697.ref038" ref-type="bibr">38</xref>].</p><table-wrap position="float" id="pone.0323697.t002"><object-id pub-id-type="doi">10.1371/journal.pone.0323697.t002</object-id><label>Table 2</label><caption><title>The comparison between the detection limits for the ANN models created in this work with those published in the literature.</title></caption><alternatives><graphic xlink:href="pone.0323697.t002" id="pone.0323697.t002g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Hormone</th><th align="left" colspan="2" rowspan="1">Limit of detection (LOD) (ng/ml)</th><th align="left" colspan="2" rowspan="1">Limit of quantification (LOQ) (ng/ml)</th><th align="left" rowspan="2" colspan="1">Reported LOD in literature (ng/ml)</th><th align="left" rowspan="2" colspan="1">Reported LOQ in literature (ng/ml)</th><th align="left" rowspan="2" colspan="1">References</th></tr><tr><th align="left" rowspan="1" colspan="1">LOD<sub>min</sub></th><th align="left" rowspan="1" colspan="1">LOD<sub>max</sub></th><th align="left" rowspan="1" colspan="1">LOQ<sub>min</sub></th><th align="left" rowspan="1" colspan="1">LOQ<sub>max</sub></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Growth hormone</td><td align="left" rowspan="1" colspan="1">0.3222</td><td align="left" rowspan="1" colspan="1">42.33</td><td align="left" rowspan="1" colspan="1">0.9766</td><td align="left" rowspan="1" colspan="1">128.28</td><td align="left" rowspan="1" colspan="1">0.04 (ELISA) and 0.5 (IDMS)</td><td align="left" rowspan="1" colspan="1">0.065 (ELISA) and 0.7 (IDMS)</td><td align="left" rowspan="1" colspan="1">[<xref rid="pone.0323697.ref028" ref-type="bibr">28</xref>,<xref rid="pone.0323697.ref036" ref-type="bibr">36</xref>,<xref rid="pone.0323697.ref037" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Testosterone</td><td align="left" rowspan="1" colspan="1">0.1851</td><td align="left" rowspan="1" colspan="1">18.57</td><td align="left" rowspan="1" colspan="1">0.5611</td><td align="left" rowspan="1" colspan="1">56.28</td><td align="left" rowspan="1" colspan="1">0.2 (LC-HRMS) and 0.05&#x02013;0.2 (NanoLC-HRMS/MS)</td><td align="left" rowspan="1" colspan="1">0.5 (LC-HRMS)</td><td align="left" rowspan="1" colspan="1">[<xref rid="pone.0323697.ref034" ref-type="bibr">34</xref>,<xref rid="pone.0323697.ref035" ref-type="bibr">35</xref>]</td></tr></tbody></table></alternatives></table-wrap><p>The average values of the predicted concentration levels of the respective hormones were determined before and some hours after injection (0.5, 2, 4, 8, and 24 hours) in each of the groups (injected and non-injected). <xref rid="pone.0323697.g007" ref-type="fig">Fig 7</xref> displays GH and TE hormone levels (on average) in blood taken from GH with/and TE injected and non-injected SD rats throughout the 24 hours of study.</p><fig position="float" id="pone.0323697.g007"><object-id pub-id-type="doi">10.1371/journal.pone.0323697.g007</object-id><label>Fig 7</label><caption><title>Predicted concentrations using the (a) GH and (b) TE ANN models.</title></caption><graphic xlink:href="pone.0323697.g007" position="float"/></fig><p>The administration of GH led to a rapid elevation in GH levels within half an hour, reaching a peak concentration of 44&#x02009;ng/ml, indicating the prompt bioavailability and uptake of exogenous GH. This elevation in GH levels was sustained for a brief period before gradually declining, although remaining elevated compared to baseline levels (<xref rid="pone.0323697.g006" ref-type="fig">Fig 6a</xref>). The return of GH levels to normal after 24 hours suggests the transient nature of exogenous GH effects, with hormonal homeostasis being restored over time. Similarly, administration of TE resulted in a progressive increase in TE levels over time, peaking between half an hour and eight hours post-injection (<xref rid="pone.0323697.g006" ref-type="fig">Fig 6b</xref>), consistent with the expected pharmacokinetic profile of TE. Interestingly, concurrent administration of TE and GH did not significantly alter the temporal pattern of TE elevation compared to TE alone, indicating independent mechanisms of action for these hormones [<xref rid="pone.0323697.ref039" ref-type="bibr">39</xref>]. Importantly, TE levels returned to baseline after 24 hours across all treatment groups, underscoring the transient nature of TE effects and the efficient metabolism and elimination of exogenous TE. The observed changes in hormone levels highlight the dynamic interplay between exogenously administered hormones and endogenous hormonal regulation mechanisms. The rapid elevation and subsequent decline in GH levels reflect the pulsatile nature of GH secretion and the regulatory feedback mechanisms that maintain hormonal balance [<xref rid="pone.0323697.ref038" ref-type="bibr">38</xref>]. Similarly, the temporal profile of TE levels reflects its pharmacokinetic properties, including absorption, distribution, metabolism, and elimination processes.</p><p>To validate the data obtained, ELISA was used and the results are displayed in <xref rid="pone.0323697.g008" ref-type="fig">Fig 8</xref>. Here ELISA standard curves of each hormone was plotted as a graph of optical density against the known concentration as in <xref rid="pone.0323697.g008" ref-type="fig">Fig 8a</xref> for GH and <xref rid="pone.0323697.g008" ref-type="fig">Fig 8b</xref> for TE. A best-fit curve, i.e., a Boltzmann function (for GH) and exponential decay function (for TE), was then applied to these points to establish a relationship between concentration and optical density. This fit allowed for prediction of the concentrations of GH and TE hormones in unknown blood samples by comparing their optical density to the standard curve (see <xref rid="pone.0323697.g008" ref-type="fig">Fig 8c</xref> and <xref rid="pone.0323697.g008" ref-type="fig">8d</xref>).</p><fig position="float" id="pone.0323697.g008"><object-id pub-id-type="doi">10.1371/journal.pone.0323697.g008</object-id><label>Fig 8</label><caption><title>ELISA results for non-injected rats and rats injected singly and simultaneously with GH and TE hormones.</title></caption><graphic xlink:href="pone.0323697.g008" position="float"/></fig><p>As seen from the standard curves, the data showed an excellent fit, with the coefficient of determination values being nearly one, i.e., 0.99946 for GH (<xref rid="pone.0323697.g008" ref-type="fig">Fig 8a</xref>) and 0.99733 for TE (<xref rid="pone.0323697.g008" ref-type="fig">Fig 8b</xref>). The predicted concentration by ELISA, was noted to correlate with those concentrations obtained by the ANN models. Initially, GH concentrations in both non-injected rats and rats injected with hormones were within normal ranges (3&#x02009;ng/ml), indicating baseline physiological levels. However, following GH injection, GH concentrations rapidly increased, reaching peak levels (26&#x02009;ng/ml) within two hours post-injection, before returning to baseline levels by four hours. This temporal profile suggests a transient elevation in GH concentrations, with exogenously administered GH being detectable in the bloodstream for up to two hours post-injection. Beyond this timeframe, GH concentrations reverted to normal levels, underscoring the limited duration of exogenous GH detection using the ELISA kit employed in our study. Conversely, TE levels at baseline were also within normal ranges in both non-injected rats and rats injected with hormones (2&#x02009;ng/ml). Following TE injection, TE concentrations gradually increased, peaking at two hours for rats injected with TE alone and at eight hours for rats injected simultaneously with GH and TE. This sustained elevation in TE concentrations suggests a prolonged presence of exogenously administered TE in the bloodstream, with detectable levels lasting up to eight hours post-injection. Importantly, these findings are consistent with results obtained from SERS with ANN models, providing additional validation of the ELISA kit results.</p><p>The accuracy and dependability of various analytical methods for measuring hormone concentrations after exogenous injection can be better understood by comparing the results of ELISA and SERS with ANN. In this study, significant similarities as well as differences between the two approaches&#x02019; temporal profiles of GH and TE concentrations were noted. As demonstrated by the findings of the ELISA and SERS with ANN, the injection of GH triggered a rapid and sustained rise in GH levels within the first two hours after the injection. The GH concentration that peaked between 30 minutes and 2 hours after injection and then gradually decreased is consistent with the pharmacokinetic profile of GH that is given exogenously. This consistency between SERS with ANN and ELISA results underscores the reliability of both techniques in capturing the dynamic changes in GH concentrations over time. Similarly, the administration of TE led to a progressive increase in TE levels over time, peaking between half an hour and eight hours post-injection, as observed with both SERS with ANN and ELISA methods. The sustained elevation in TE concentrations and the prolonged detection window of up to eight hours post-injection are consistent across both analytical techniques, reflecting the pharmacokinetic properties of exogenously administered TE. Additionally, both SERS with ANN and ELISA results showed that simultaneous injection of TE and GH did not significantly change the temporal patterns of TE concentrations compared to TE alone. It indicates that TE and GH have separate modes of action, with neither hormone significantly interfering with the other&#x02019;s ability to affect hormone concentrations. The validity of SERS with ANN in capturing the temporal changes of GH and TE concentrations is therefore demonstrated by the consistency of the hormone quantification results between SERS with ANN and ELISA technique. This demonstrates that the combination of SERS with ANN provides a label-free, non-destructive approach for multiplexed hormone measurement, with possible advantages in terms of sample throughput and adaptability.</p></sec></sec><sec id="sec009"><title>4. Conclusion</title><p>This work has demonstrated the ability of SERS together with ANN models in quantifying the GH and TE hormone levels in blood of male SD rats. Here, two ANN models were developed based on six PC scores obtained from the PCA of different concentrations of each of the hormones in blood. A test for the model&#x02019;s accuracy was done using R<sup>2</sup> and RMSE values that were seen to be greater than 87.71% and less than 0.6436 respectively implying the models were accurate. The minimum limit of detection (LOD) deduced were 0.3222&#x02009;ng/ml (for GH) and 0.1851&#x02009;ng/ml (for TE) while the minimum limit of quantification (LOQ) determined were 0.9766&#x02009;ng/ml (for GH) and 0.5611&#x02009;ng/ml (for TE). This detection limits were very low and thus acceptable. Using the calibrated ANN models in determining the concentration hormone level in blood of rats, it was noted that hormone injected rats&#x02019; respective hormone levels elevated for some time and declined later when compared to those of non-injected rats. This implied that exogenous injection of sport dopants can be detected and quantified using SERS technique combined with ANN models. This could bring about the customization of a SERS system that utilizes SERS data and inbuilt ANN models to detect GH and TE levels in blood in less than a minute. These findings widen the potential use of SERS in sports science, clinical diagnostics, and biomedical research.</p></sec></body><back><ref-list><title>References</title><ref id="pone.0323697.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Kraemer</surname><given-names>WJ</given-names></name>, <name><surname>Ratamess</surname><given-names>NA</given-names></name>, <name><surname>Hymer</surname><given-names>WC</given-names></name>, <name><surname>Nindl</surname><given-names>BC</given-names></name>, <name><surname>Fragala</surname><given-names>MS</given-names></name>. <article-title>Growth Hormone(s), Testosterone, Insulin-Like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth With Exercise</article-title>. <source>Front Endocrinol (Lausanne)</source>. <year>2020</year>;<volume>11</volume>:<fpage>33</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fendo.2020.00033</pub-id>
<pub-id pub-id-type="pmid">32158429</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Ahmetov</surname><given-names>II</given-names></name>, <name><surname>Roos</surname><given-names>TR</given-names></name>, <name><surname>Stepanova</surname><given-names>AA</given-names></name>, <name><surname>Biktagirova</surname><given-names>EM</given-names></name>, <name><surname>Semenova</surname><given-names>EA</given-names></name>, <name><surname>Shchuplova</surname><given-names>IS</given-names></name>, <etal>et al</etal>. <article-title>Is testosterone responsible for athletic success in female athletes?</article-title>
<source>bioRxiv</source>. <year>2019</year>;<fpage>557348</fpage>.</mixed-citation></ref><ref id="pone.0323697.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Rani</surname><given-names>S</given-names></name>, <name><surname>Chandna</surname><given-names>P</given-names></name>. <article-title>Multiomics analysis-based biomarkers in diagnosis of polycystic ovary syndrome</article-title>. <source>Reprod Sci</source>. <year>2023</year>;<volume>30</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>27</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s43032-022-00863-9</pub-id>
<pub-id pub-id-type="pmid">35084716</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Siebert</surname><given-names>DM</given-names></name>, <name><surname>Rao</surname><given-names>AL</given-names></name>. <article-title>The use and abuse of human growth hormone in sports</article-title>. <source>Sports Health</source>. <year>2018</year>;<volume>10</volume>(<issue>5</issue>):<fpage>419</fpage>&#x02013;<lpage>26</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/1941738118782688</pub-id>
<pub-id pub-id-type="pmid">29932857</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Ondieki</surname><given-names>AM</given-names></name>, <name><surname>Birech</surname><given-names>Z</given-names></name>, <name><surname>Kaduki</surname><given-names>KA</given-names></name>, <name><surname>Mwangi</surname><given-names>PW</given-names></name>, <name><surname>Juma</surname><given-names>M</given-names></name>, <name><surname>Chege</surname><given-names>BM</given-names></name>. <article-title>Label-free assaying of testosterone and growth hormones in blood using surface-enhanced Raman spectroscopy</article-title>. <source>Vibr Spectrosc</source>. <year>2023</year>;<volume>129</volume>:<fpage>103605</fpage>.</mixed-citation></ref><ref id="pone.0323697.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Tian</surname><given-names>W</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Lei</surname><given-names>H</given-names></name>, <name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Xiao</surname><given-names>Z</given-names></name>. <article-title>Antibody production and application for immunoassay development of environmental hormones: a review</article-title>. <source>Chem Biol Technol Agric</source>. <year>2018</year>;<volume>5</volume>(<issue>1</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s40538-018-0117-0</pub-id></mixed-citation></ref><ref id="pone.0323697.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Gravitte</surname><given-names>A</given-names></name>, <name><surname>Archibald</surname><given-names>T</given-names></name>, <name><surname>Cobble</surname><given-names>A</given-names></name>, <name><surname>Kennard</surname><given-names>B</given-names></name>, <name><surname>Brown</surname><given-names>S</given-names></name>. <article-title>Liquid chromatography&#x02013;mass spectrometry applications for quantification of endogenous sex hormones</article-title>. <source>Biomedical Chromatography</source>. <year>2020</year>;<volume>35</volume>(<issue>1</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/bmc.5036</pub-id></mixed-citation></ref><ref id="pone.0323697.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Otange</surname><given-names>BO</given-names></name>, <name><surname>Birech</surname><given-names>Z</given-names></name>, <name><surname>Okonda</surname><given-names>J</given-names></name>, <name><surname>Rop</surname><given-names>R</given-names></name>. <article-title>Conductive silver paste smeared glass substrates for label-free Raman spectroscopic detection of HIV-1 and HIV-1 p24 antigen in blood plasma</article-title>. <source>Anal Bioanal Chem</source>. <year>2017</year>;<volume>409</volume>(<issue>12</issue>):<fpage>3253</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00216-017-0267-0</pub-id>
<pub-id pub-id-type="pmid">28255920</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Malekzad</surname><given-names>H</given-names></name>, <name><surname>Zangabad</surname><given-names>PS</given-names></name>, <name><surname>Mohammadi</surname><given-names>H</given-names></name>, <name><surname>Sadroddini</surname><given-names>M</given-names></name>, <name><surname>Jafari</surname><given-names>Z</given-names></name>, <name><surname>Mahlooji</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Noble metal nanostructures in optical biosensors: Basics, and their introduction to anti-doping detection</article-title>. <source>Trends Analyt Chem</source>. <year>2018</year>;<volume>100</volume>:<fpage>116</fpage>&#x02013;<lpage>35</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.trac.2017.12.006</pub-id>
<pub-id pub-id-type="pmid">29731530</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Ondieki</surname><given-names>AM</given-names></name>, <name><surname>Birech</surname><given-names>Z</given-names></name>, <name><surname>Kaduki</surname><given-names>KA</given-names></name>, <name><surname>Kaingu</surname><given-names>CK</given-names></name>, <name><surname>Ndeke</surname><given-names>AN</given-names></name>, <name><surname>Namanya</surname><given-names>L</given-names></name>. <article-title>Biomarker Raman bands of estradiol, follicle-stimulating, luteinizing, and progesterone hormones in blood</article-title>. <source>Vibrational Spectroscopy</source>. <year>2022</year>;<volume>122</volume>:<fpage>103425</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.vibspec.2022.103425</pub-id></mixed-citation></ref><ref id="pone.0323697.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Chege</surname><given-names>BM</given-names></name>, <name><surname>Birech</surname><given-names>Z</given-names></name>, <name><surname>Mwangi</surname><given-names>PW</given-names></name>, <name><surname>Bukachi</surname><given-names>FO</given-names></name>. <article-title>Utility of Raman spectroscopy in diabetes detection based on biomarker Raman bands and in antidiabetic efficacy studies of herbal extract Rotheca myricoides Hochst</article-title>. <source>J Raman Spectroscopy</source>. <year>2019</year>;<volume>50</volume>(<issue>10</issue>):<fpage>1358</fpage>&#x02013;<lpage>66</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/jrs.5619</pub-id></mixed-citation></ref><ref id="pone.0323697.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Birech</surname><given-names>Z</given-names></name>, <name><surname>Mwangi</surname><given-names>PW</given-names></name>, <name><surname>Bukachi</surname><given-names>F</given-names></name>, <name><surname>Mandela</surname><given-names>KM</given-names></name>. <article-title>Application of Raman spectroscopy in type 2 diabetes screening in blood using leucine and isoleucine amino-acids as biomarkers and in comparative anti-diabetic drugs efficacy studies</article-title>. <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>(<issue>9</issue>):e0185130. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0185130</pub-id>
<pub-id pub-id-type="pmid">28926628</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Bell</surname><given-names>SEJ</given-names></name>, <name><surname>Charron</surname><given-names>G</given-names></name>, <name><surname>Cort&#x000e9;s</surname><given-names>E</given-names></name>, <name><surname>Kneipp</surname><given-names>J</given-names></name>, <name><surname>de la Chapelle</surname><given-names>ML</given-names></name>, <name><surname>Langer</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Towards Reliable and Quantitative Surface-Enhanced Raman Scattering (SERS): From Key Parameters to Good Analytical Practice</article-title>. <source>Angew Chem Int Ed Engl</source>. <year>2020</year>;<volume>59</volume>(<issue>14</issue>):<fpage>5454</fpage>&#x02013;<lpage>62</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/anie.201908154</pub-id>
<pub-id pub-id-type="pmid">31588641</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>C</given-names></name>, <name><surname>Yu</surname><given-names>C</given-names></name>. <article-title>Analytical characterization using surface-enhanced Raman scattering (SERS) and microfluidic sampling</article-title>. <source>Nanotechnology</source>. <year>2015</year>;<volume>26</volume>(<issue>9</issue>):<fpage>092001</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1088/0957-4484/26/9/092001</pub-id>
<pub-id pub-id-type="pmid">25676092</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Jones</surname><given-names>RR</given-names></name>, <name><surname>Hooper</surname><given-names>DC</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Wolverson</surname><given-names>D</given-names></name>, <name><surname>Valev</surname><given-names>VK</given-names></name>. <article-title>Raman techniques: fundamentals and frontiers</article-title>. <source>Nanoscale Res Lett</source>. <year>2019</year>;<volume>14</volume>(<issue>1</issue>):<fpage>231</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s11671-019-3039-2</pub-id>
<pub-id pub-id-type="pmid">31300945</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>J</given-names></name>, <name><surname>Agyekum</surname><given-names>AA</given-names></name>, <name><surname>Kutsanedzie</surname><given-names>FYH</given-names></name>, <name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Chen</surname><given-names>Q</given-names></name>, <name><surname>Ouyang</surname><given-names>Q</given-names></name>, <etal>et al</etal>. <article-title>Qualitative and quantitative analysis of chlorpyrifos residues in tea by surface-enhanced Raman spectroscopy (SERS) combined with chemometric models</article-title>. <source>LWT</source>. <year>2018</year>;<volume>97</volume>:<fpage>760</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.lwt.2018.07.055</pub-id></mixed-citation></ref><ref id="pone.0323697.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Weng</surname><given-names>S</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Chen</surname><given-names>C</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>, <name><surname>Zheng</surname><given-names>S</given-names></name>, <name><surname>Zeng</surname><given-names>X</given-names></name>. <article-title>Fast and accurate determination of organophosphate pesticides using surface-enhanced Raman scattering and chemometrics</article-title>. <source>Anal Methods</source>. <year>2015</year>;<volume>7</volume>(<issue>6</issue>):<fpage>2563</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1039/c4ay03067b</pub-id></mixed-citation></ref><ref id="pone.0323697.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Kou</surname><given-names>Q</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Detection and identification of estrogen based on surface-enhanced resonance Raman scattering (SERRS)</article-title>. <source>Molecules</source>. <year>2018</year>;<volume>23</volume>(<issue>6</issue>):<fpage>1330</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/molecules23061330</pub-id>
<pub-id pub-id-type="pmid">29857591</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref019"><label>19</label><mixed-citation publication-type="other">Alvarez-Puebla RA, Blanco-Formoso M. Cancer diagnosis through SERS and other related techniques. 2020.</mixed-citation></ref><ref id="pone.0323697.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Galata</surname><given-names>DL</given-names></name>, <name><surname>Farkas</surname><given-names>A</given-names></name>, <name><surname>K&#x000f6;nyves</surname><given-names>Z</given-names></name>, <name><surname>M&#x000e9;sz&#x000e1;ros</surname><given-names>LA</given-names></name>, <name><surname>Szab&#x000f3;</surname><given-names>E</given-names></name>, <name><surname>Csontos</surname><given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Fast, spectroscopy-based prediction of in vitro dissolution profile of extended release tablets using artificial neural networks</article-title>. <source>Pharmaceutics</source>. <year>2019</year>;<volume>11</volume>(<issue>8</issue>):<fpage>400</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/pharmaceutics11080400</pub-id>
<pub-id pub-id-type="pmid">31405029</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Vendrell-Dones</surname><given-names>MO</given-names></name>, <name><surname>Deriu</surname><given-names>C</given-names></name>, <name><surname>Do&#x0011f;ruer</surname><given-names>S</given-names></name>, <name><surname>de B Harrington</surname><given-names>P</given-names></name>, <name><surname>McCord</surname><given-names>B</given-names></name>. <article-title>Multivariate Analysis Aided Surface-Enhanced Raman Spectroscopy (MVA-SERS) Multiplex Quantitative Detection of Trace Fentanyl in Illicit Drug Mixtures Using a Handheld Raman Spectrometer</article-title>. <source>Appl Spectrosc</source>. <year>2021</year>;<volume>75</volume>(<issue>10</issue>):<fpage>1225</fpage>&#x02013;<lpage>36</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/00037028211032930</pub-id>
<pub-id pub-id-type="pmid">34318708</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Jafari</surname><given-names>S</given-names></name>, <name><surname>Guercetti</surname><given-names>J</given-names></name>, <name><surname>Geballa-Koukoula</surname><given-names>A</given-names></name>, <name><surname>Tsagkaris</surname><given-names>AS</given-names></name>, <name><surname>Nelis</surname><given-names>JLD</given-names></name>, <name><surname>Marco</surname><given-names>M-P</given-names></name>, <etal>et al</etal>. <article-title>ASSURED Point-of-Need Food Safety Screening: A Critical Assessment of Portable Food Analyzers</article-title>. <source>Foods</source>. <year>2021</year>;<volume>10</volume>(<issue>6</issue>):<fpage>1399</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/foods10061399</pub-id>
<pub-id pub-id-type="pmid">34204284</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Ribeiro de Oliveira Longo Schweizer</surname><given-names>J</given-names></name>, <name><surname>Ribeiro-Oliveira A</surname><given-names>Jr</given-names></name>, <name><surname>Bidlingmaier</surname><given-names>M</given-names></name>. <article-title>Growth hormone: isoforms, clinical aspects and assays interference</article-title>. <source>Clin Diabetes Endocrinol</source>. <year>2018</year>;<volume>4</volume>:<fpage>18</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s40842-018-0068-1</pub-id>
<pub-id pub-id-type="pmid">30181896</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref024"><label>24</label><mixed-citation publication-type="book"><name><surname>Carey</surname><given-names>K</given-names></name>. <source>The detection of doping in sport and the role of forensic science</source>. <year>2018</year>.</mixed-citation></ref><ref id="pone.0323697.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Ondieki</surname><given-names>AM</given-names></name>, <name><surname>Birech</surname><given-names>Z</given-names></name>, <name><surname>Kaduki</surname><given-names>KA</given-names></name>, <name><surname>Mwangi</surname><given-names>PW</given-names></name>, <name><surname>Mwenze</surname><given-names>NM</given-names></name>, <name><surname>Juma</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Fabrication of surface-enhanced Raman spectroscopy substrates using silver nanoparticles produced by laser ablation in liquids</article-title>. <source>Spectrochim Acta A Mol Biomol Spectrosc</source>. <year>2023</year>;<volume>296</volume>:<fpage>122694</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.saa.2023.122694</pub-id>
<pub-id pub-id-type="pmid">37030254</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Allegrini</surname><given-names>F</given-names></name>, <name><surname>Olivieri</surname><given-names>AC</given-names></name>. <article-title>Sensitivity, Prediction Uncertainty, and Detection Limit for Artificial Neural Network Calibrations</article-title>. <source>Anal Chem</source>. <year>2016</year>;<volume>88</volume>(<issue>15</issue>):<fpage>7807</fpage>&#x02013;<lpage>12</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1021/acs.analchem.6b01857</pub-id>
<pub-id pub-id-type="pmid">27363813</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref027"><label>27</label><mixed-citation publication-type="book"><name><surname>Desimoni</surname><given-names>E</given-names></name>, <name><surname>Brunetti</surname><given-names>B</given-names></name>. <source>About estimating the limit of detection by the signal to noise approach</source>. <year>2015</year>.</mixed-citation></ref><ref id="pone.0323697.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Steyn</surname><given-names>FJ</given-names></name>, <name><surname>Huang</surname><given-names>L</given-names></name>, <name><surname>Ngo</surname><given-names>ST</given-names></name>, <name><surname>Leong</surname><given-names>JW</given-names></name>, <name><surname>Tan</surname><given-names>HY</given-names></name>, <name><surname>Xie</surname><given-names>TY</given-names></name>, <etal>et al</etal>. <article-title>Development of a method for the determination of pulsatile growth hormone secretion in mice</article-title>. <source>Endocrinology</source>. <year>2011</year>;<volume>152</volume>(<issue>8</issue>):<fpage>3165</fpage>&#x02013;<lpage>71</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1210/en.2011-0253</pub-id>
<pub-id pub-id-type="pmid">21586549</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Pataky</surname><given-names>MW</given-names></name>, <name><surname>Young</surname><given-names>WF</given-names></name>, <name><surname>Nair</surname><given-names>KS</given-names></name>. <article-title>Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications</article-title>. <source>Mayo Clin Proc</source>. <year>2021</year>;<volume>96</volume>(<issue>3</issue>):<fpage>788</fpage>&#x02013;<lpage>814</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.mayocp.2020.07.033</pub-id>
<pub-id pub-id-type="pmid">33673927</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>X</given-names></name>, <name><surname>Hu</surname><given-names>Z</given-names></name>, <name><surname>Yang</surname><given-names>D</given-names></name>, <name><surname>Xie</surname><given-names>S</given-names></name>, <name><surname>Jiang</surname><given-names>Z</given-names></name>, <name><surname>Niessner</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Bacteria Detection: From Powerful SERS to Its Advanced Compatible Techniques</article-title>. <source>Adv Sci (Weinh)</source>. <year>2020</year>;<volume>7</volume>(<issue>23</issue>):<fpage>2001739</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/advs.202001739</pub-id>
<pub-id pub-id-type="pmid">33304748</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Barkur</surname><given-names>S</given-names></name>, <name><surname>Chidangil</surname><given-names>S</given-names></name>. <article-title>Surface-enhanced Raman spectroscopy study of red blood cells and platelets</article-title>. <source>J Biomol Struct Dyn</source>. <year>2019</year>;<volume>37</volume>(<issue>4</issue>):<fpage>1090</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/07391102.2018.1450165</pub-id>
<pub-id pub-id-type="pmid">29519212</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Jalaja</surname><given-names>K</given-names></name>, <name><surname>Al-Alshaikh</surname><given-names>MA</given-names></name>, <name><surname>Mary</surname><given-names>YS</given-names></name>, <name><surname>Panicker</surname><given-names>CY</given-names></name>, <name><surname>El-Emam</surname><given-names>AA</given-names></name>, <name><surname>Temiz-Arpaci</surname><given-names>O</given-names></name>, <etal>et al</etal>. <article-title>Vibrational spectroscopic investigations and molecular docking studies of biologically active 2-[4-(4-phenylbutanamido)phenyl]-5-ethylsulphonyl-benzoxazole</article-title>. <source>Journal of Molecular Structure</source>. <year>2017</year>;<volume>1148</volume>:<fpage>119</fpage>&#x02013;<lpage>33</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.molstruc.2017.07.023</pub-id></mixed-citation></ref><ref id="pone.0323697.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Bonnier</surname><given-names>F</given-names></name>, <name><surname>Byrne</surname><given-names>HJ</given-names></name>. <article-title>Understanding the molecular information contained in principal component analysis of vibrational spectra of biological systems</article-title>. <source>Analyst</source>. <year>2012</year>;<volume>137</volume>(<issue>2</issue>):<fpage>322</fpage>&#x02013;<lpage>32</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1039/c1an15821j</pub-id>
<pub-id pub-id-type="pmid">22114757</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Solheim</surname><given-names>SA</given-names></name>, <name><surname>Levernaes</surname><given-names>MCS</given-names></name>, <name><surname>M&#x000f8;rkeberg</surname><given-names>J</given-names></name>, <name><surname>Juul</surname><given-names>A</given-names></name>, <name><surname>Upners</surname><given-names>EN</given-names></name>, <name><surname>Nordsborg</surname><given-names>NB</given-names></name>, <etal>et al</etal>. <article-title>Stability and detectability of testosterone esters in dried blood spots after intramuscular injections</article-title>. <source>Drug Test Anal</source>. <year>2022</year>;<volume>14</volume>(11&#x02013;12):<fpage>1926</fpage>&#x02013;<lpage>37</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/dta.3030</pub-id>
<pub-id pub-id-type="pmid">33733610</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Jing</surname><given-names>J</given-names></name>, <name><surname>Shan</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>Z</given-names></name>, <name><surname>Yan</surname><given-names>H</given-names></name>, <name><surname>Xiang</surname><given-names>P</given-names></name>, <name><surname>Chen</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Automated online dried blood spot sample preparation and detection of anabolic steroid esters for sports drug testing</article-title>. <source>Drug Test Anal</source>. <year>2022</year>;<volume>14</volume>(<issue>6</issue>):<fpage>1040</fpage>&#x02013;<lpage>52</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/dta.3226</pub-id>
<pub-id pub-id-type="pmid">35060358</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>GD</given-names></name>, <name><surname>Husk</surname><given-names>J</given-names></name>, <name><surname>Crouch</surname><given-names>AK</given-names></name>, <name><surname>Eichner</surname><given-names>D</given-names></name>. <article-title>Growth hormone isoform testing in capillary dried blood spots: Results from single and multiple dose administration studies and large-scale field collections</article-title>. <source>Drug Test Anal</source>. <year>2022</year>;<volume>14</volume>(<issue>7</issue>):<fpage>1255</fpage>&#x02013;<lpage>63</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/dta.3248</pub-id>
<pub-id pub-id-type="pmid">35249266</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Arsene</surname><given-names>CG</given-names></name>, <name><surname>Henrion</surname><given-names>A</given-names></name>, <name><surname>Diekmann</surname><given-names>N</given-names></name>, <name><surname>Manolopoulou</surname><given-names>J</given-names></name>, <name><surname>Bidlingmaier</surname><given-names>M</given-names></name>. <article-title>Quantification of growth hormone in serum by isotope dilution mass spectrometry</article-title>. <source>Anal Biochem</source>. <year>2010</year>;<volume>401</volume>(<issue>2</issue>):<fpage>228</fpage>&#x02013;<lpage>35</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ab.2010.03.005</pub-id>
<pub-id pub-id-type="pmid">20226156</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Holt</surname><given-names>RIG</given-names></name>, <name><surname>Ho</surname><given-names>KKY</given-names></name>. <article-title>The Use and Abuse of Growth Hormone in Sports</article-title>. <source>Endocr Rev</source>. <year>2019</year>;<volume>40</volume>(<issue>4</issue>):<fpage>1163</fpage>&#x02013;<lpage>85</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1210/er.2018-00265</pub-id>
<pub-id pub-id-type="pmid">31180479</pub-id>
</mixed-citation></ref><ref id="pone.0323697.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Gibney</surname><given-names>J</given-names></name>, <name><surname>Wolthers</surname><given-names>T</given-names></name>, <name><surname>Johannsson</surname><given-names>G</given-names></name>, <name><surname>Umpleby</surname><given-names>AM</given-names></name>, <name><surname>Ho</surname><given-names>KKY</given-names></name>. <article-title>Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2005</year>;<volume>289</volume>(<issue>2</issue>):E266&#x02013;<lpage>71</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1152/ajpendo.00483.2004</pub-id>
<pub-id pub-id-type="pmid">15727949</pub-id>
</mixed-citation></ref></ref-list></back><sub-article article-type="author-comment" id="pone.0323697.r001" specific-use="rebutted-decision-letter-unavailable"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0323697.r001</article-id><title-group><article-title>Author response to Decision Letter 0</article-title></title-group><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>0</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="author-response-date">23 Feb 2025</named-content>
</p><supplementary-material id="pone.0323697.s001" position="float" content-type="local-data"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">Reviewercomments_letter2.pdf</named-content></p></caption><media xlink:href="pone.0323697.s001.pdf"/></supplementary-material></body></sub-article><sub-article article-type="aggregated-review-documents" id="pone.0323697.r002" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0323697.r002</article-id><title-group><article-title>Decision Letter 0</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tabish</surname><given-names>Tanveer</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2025 Tanveer Tabish</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Tanveer Tabish</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0323697" id="rel-obj002" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>0</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">24 Mar 2025</named-content>
</p><p>PONE-D-25-09375Chemometrics-aided Surface-enhanced Raman spectrometric detection and quantification of GH and TE hormones in bloodPLOS ONE</p><p>Dear Dr. Ondieki,</p><p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE&#x02019;s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p><p>Please submit your revised manuscript by May 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at&#x000a0;<email>plosone@plos.org</email> . When you're ready to submit your revision, log on to <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p><p>Please include the following items when submitting your revised manuscript:</p><p><list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list>
</p><p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p><p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link xlink:href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" ext-link-type="uri">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link> . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link xlink:href="https://plos.org/protocols?utm_medium=editorial-email&#x00026;utm_source=authorletters&#x00026;utm_campaign=protocols" ext-link-type="uri">https://plos.org/protocols?utm_medium=editorial-email&#x00026;utm_source=authorletters&#x00026;utm_campaign=protocols</ext-link> .</p><p>We look forward to receiving your revised manuscript.</p><p>Kind regards,</p><p>Tanveer A. Tabish</p><p>Academic Editor</p><p>PLOS ONE</p><p>Journal requirements:</p><p>When submitting your revision, we need you to address these additional requirements.</p><p>1.&#x000a0; Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p><p><ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> &#x000a0; and</p><p>
<ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link>
</p><p>2. Thank you for stating the following financial disclosure:</p><p>&#x0201c;Swedish International Development Cooperation Agency (SIDA) through the International Science Programme (ISP), Uppsala University, KEN:04, Prof. Kenneth A. Kaduki&#x0201d;</p><p>Please state what role the funders took in the study.&#x000a0; If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."</p><p>If this statement is not correct you must amend it as needed.</p><p>Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.</p><p>3. Thank you for stating the following in the Acknowledgments Section of your manuscript:</p><p>&#x0201c;We sincerely express our gratitude to the Swedish International Development Cooperation Agency (SIDA) through the International Science Programme (ISP), Uppsala University, for sponsoring this research.&#x0201d;</p><p>We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.</p><p>Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:</p><p>&#x0201c;Swedish International Development Cooperation Agency (SIDA) through the International Science Programme (ISP), Uppsala University, KEN:04, Prof. Kenneth A. Kaduki&#x0201d;</p><p>Please include your amended statements within your cover letter; we will change the online submission form on your behalf.</p><p>[Note: HTML markup is below. Please do not edit.]</p><p>Reviewers' comments:</p><p>Reviewer's Responses to Questions</p><p>
<bold>Comments to the Author</bold>
</p><p>1. Is the manuscript technically sound, and do the data support the conclusions?</p><p>The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. </p><p>Reviewer #1:&#x000a0;Partly</p><p>Reviewer #2:&#x000a0;Partly</p><p>**********</p><p>2. Has the statistical analysis been performed appropriately and rigorously? </p><p>Reviewer #1:&#x000a0;No</p><p>Reviewer #2:&#x000a0;Yes</p><p>**********</p><p>3. Have the authors made all data underlying the findings in their manuscript fully available?</p><p>The <ext-link xlink:href="http://www.plosone.org/static/policies.action#sharing" ext-link-type="uri">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data&#x02014;e.g. participant privacy or use of data from a third party&#x02014;those must be specified.</p><p>Reviewer #1:&#x000a0;Yes</p><p>Reviewer #2:&#x000a0;Yes</p><p>**********</p><p>4. Is the manuscript presented in an intelligible fashion and written in standard English?</p><p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.</p><p>Reviewer #1:&#x000a0;Yes</p><p>Reviewer #2:&#x000a0;No</p><p>**********</p><p>5. Review Comments to the Author</p><p>Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)</p><p>Reviewer #1:&#x000a0;This manuscript presents a quantitative detection of hormones using SERS with a portable Raman spectrometer. The SERS spectra of whole blood from rats injected with hormones are distinguished from those of control samples (without hormone injection) through chemometric analysis. Furthermore, the authors examine temporal variations at different time points following hormone injection. Notably, hormone concentrations are predicted via SERS using an artificial neural network (ANN) model, and the temporal trends appear to be roughly consistent with those obtained through ELISA. The rapid detection of hormones is of significant importance, as it pertains to health monitoring, doping control, and related applications. However, there may be statistical issues. Therefore, I can recommend publication after resolving the following concerns.</p><p>Fig. 1: Are these spectra averaged? If so, the number of spectra used to obtain the average should be specified. Additionally, are these spectra normalized? If so, this should be explicitly stated.</p><p>Lines 189&#x02013;192: Does the observed difference exceed the spectral deviation? A statistical analysis should be conducted to confirm this.</p><p>Fig. 4: The 3D plots provide limited clarity in distinguishing the temporal variations among (a)&#x02013;(d). To enhance interpretability, corresponding 2D plots should also be provided.</p><p>[Minor Comments]</p><p>Section 2.2: The fabrication method or source of AgNPs should be specified.</p><p>Lines 88&#x02013;89: "30" and "2" -&#x0003e; "Thirty" and "Two."</p><p>Lines 123, 125: The meaning of the asterisks should be clarified. Are they needed?</p><p>Lines 143&#x02013;145: This paragraph can be merged with the subsequent one, as they discuss a similar topic.</p><p>Lines 162&#x02013;164: These sentences can be integrated into the following paragraph due to thematic continuity.</p><p>Lines 199&#x02013;201: These sentences can be incorporated into the next paragraph, as they address a related topic.</p><p>Lines 242&#x02013;244: This paragraph can be merged with the preceding one due to their shared subject matter.</p><p>Lines 245&#x02013;246: This paragraph can be combined with the following one for coherence.</p><p>Line 271: A new paragraph can begin here, and the sentences up to line 275 can be merged with the subsequent paragraph, as they introduce and expand upon a related topic.</p><p>Lines 296&#x02013;302: This paragraph can be combined with the following one for improved cohesion.</p><p>Reviewer #2:&#x000a0;1, The abstract needs to be re-phrased. For example, sentences like, "Current methods of detecting them suffer from being costly, time-consuming, non-portable and others." Then, "Secondly, use of artificial neural network (ANN) models in predicting levels of these hormones in blood". Do these sentences look complete? Again, "This work explored, first, Surface-Enhanced Raman Spectroscopy (SERS)....." does not sound professional. I would appreciate it if the authors could re-phrase and reorganize these few lines. Also, I expect the authors must adopt a more professional approach in writing the abstract.</p><p>2, In the Introduction section, "The primary methods currently used to measure these hormone levels in blood are currently based on immunoassays and mass spectrometry as described in (5)". Can the authors kindly elaborate here? Include a few more references and talk about why SERS is advantageous as compared to other techniques/approaches.</p><p>3, In Fig. 1, rats injected both GH only....rats injected both TE only... Remove both.</p><p>4, For Figs. 1, 3 and 5, the Raman spectrum for different conditions cannot be easily distinguished. Although for Fig.1 it's not that bad, however, for Figs.3 and 5, the individual spectrum/peaks are not clearly visible.</p><p>It is advisable to vertically shift the individual spectrum for better clarity.</p><p>5, "The SERS spectra of blood from non-injected rats and the injected, as shown in Fig 1, are nearly identical, with a few minor band intensity variations suggesting subtle but distinct biochemical changes....". It is good to explain/justify why there is not much change/shift observed between the non-injected and injected spectra. What do the authors mean by subtle but distinct biochemical changes?</p><p>6, The authors must try to enhance the overall readability of the paper to ensure it is accessible to a broad audience. Also, please check the reference formatting.</p><p>**********</p><p>6. PLOS authors have the option to publish the peer review history of their article (<ext-link xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" ext-link-type="uri">what does this mean?</ext-link> ). If published, this will include your full peer review and any attached files.</p><p>If you choose &#x0201c;no&#x0201d;, your identity will remain anonymous but your review may still be made public.</p><p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link xlink:href="https://www.plos.org/privacy-policy" ext-link-type="uri">Privacy Policy</ext-link> .</p><p>Reviewer #1:&#x000a0;No</p><p>Reviewer #2:&#x000a0;No</p><p>**********</p><p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p><p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool,&#x000a0;<ext-link xlink:href="https://pacev2.apexcovantage.com/" ext-link-type="uri">https://pacev2.apexcovantage.com/</ext-link> . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at&#x000a0;<email>figures@plos.org</email> . Please note that Supporting Information files do not need this step.</p></body></sub-article><sub-article article-type="author-comment" id="pone.0323697.r003"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0323697.r003</article-id><title-group><article-title>Author response to Decision Letter 1</article-title></title-group><related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0323697" id="rel-obj003" related-article-type="editor-report"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="author-response-date">7 Apr 2025</named-content>
</p><p>Reviewer#1</p><p>This manuscript presents a quantitative detection of hormones using SERS with a portable Raman spectrometer. The SERS spectra of whole blood from rats injected with hormones are distinguished from those of control samples (without hormone injection) through chemometric analysis. Furthermore, the authors examine temporal variations at different time points following hormone injection. Notably, hormone concentrations are predicted via SERS using an artificial neural network (ANN) model, and the temporal trends appear to be roughly consistent with those obtained through ELISA. The rapid detection of hormones is of significant importance, as it pertains to health monitoring, doping control, and related applications. However, there may be statistical issues. Therefore, I can recommend publication after resolving the following concerns.</p><p>Major issues:</p><p>Comment 1: Fig. 1: Are these spectra averaged? If so, the number of spectra used to obtain the average should be specified. Additionally, are these spectra normalized? If so, this should be explicitly stated.</p><p>Response: Thanks for pointing out this. We have included as suggested.</p><p>Comment 2: Lines 189&#x02013;192: Does the observed difference exceed the spectral deviation? A statistical analysis should be conducted to confirm this.</p><p>Response: We appreciate for the insightful suggestion. Descriptive statistics and one-way ANOVA, has been done to confirm this.</p><p>Comment 3: Fig. 4: The 3D plots provide limited clarity in distinguishing the temporal variations among (a)&#x02013;(d). To enhance interpretability, corresponding 2D plots should also be provided.</p><p>Response: We appreciate your suggestion to include 2D plots for better clarity in distinguishing temporal variations. However, upon further analysis, we found that 2D plots do not provide significant additional segregation of the data, as the overlapping regions obscure key trends that are better visualized in the 3D representations.</p><p>Minor issues:</p><p>Comment 1: Section 2.2: The fabrication method or source of AgNPs should be specified.</p><p>Response: Included.</p><p>Comment 2: Lines 88&#x02013;89: "30" and "2" -&#x0003e; "Thirty" and "Two."</p><p>Response: Corrected.</p><p>Comment 3: Lines 123, 125: The meaning of the asterisks should be clarified. Are they needed?</p><p>Response: We have corrected this.</p><p>Comment 4: Lines 162&#x02013;164: These sentences can be integrated into the following paragraph due to thematic continuity.</p><p>Response: Combined as suggested.</p><p>Comment 5: Lines 199&#x02013;201: These sentences can be incorporated into the next paragraph, as they address a related topic.</p><p>Response: Done as suggested.</p><p>Comment 6: Lines 242&#x02013;244: This paragraph can be merged with the preceding one due to their shared subject matter.</p><p>Response: Combined.</p><p>Comment 7: Lines 245&#x02013;246: This paragraph can be combined with the following one for coherence.</p><p>Response: Combined as suggested.</p><p>Comment 8: Line 271: A new paragraph can begin here, and the sentences up to line 275 can be merged with the subsequent paragraph, as they introduce and expand upon a related topic.</p><p>Response: Done as suggested.</p><p>Comment 9: Lines 296&#x02013;302: This paragraph can be combined with the following one for improved cohesion.</p><p>Response: Done.</p><p>Reviewer#2</p><p>Comment 1: The abstract needs to be re-phrased. For example, sentences like, "Current methods of detecting them suffer from being costly, time-consuming, non-portable and others." Then, "Secondly, use of artificial neural network (ANN) models in predicting levels of these hormones in blood". Do these sentences look complete? Again, "This work explored, first, Surface-Enhanced Raman Spectroscopy (SERS)....." does not sound professional. I would appreciate it if the authors could re-phrase and reorganize these few lines. Also, I expect the authors must adopt a more professional approach in writing the abstract.</p><p>Response: We greatly appreciate your constructive feedback and suggestions for improving the abstract. Based on your comments, we have rephrased and reorganized the abstract.</p><p>Comment 2: In the Introduction section, "The primary methods currently used to measure these hormone levels in blood are currently based on immunoassays and mass spectrometry as described in (5)". Can the authors kindly elaborate here? Include a few more references and talk about why SERS is advantageous as compared to other techniques/approaches.</p><p>Response: Thanks for pointing out this. We have done as suggested.</p><p>Comment 3: In Fig. 1, rats injected both GH only....rats injected both TE only... Remove both.</p><p>Response: We appreciate your suggestion to remove the GH and TE injections from Fig. 1. However, our intention was to explore the potential combined effects of both GH and TE injections, alongside the individual effects of each hormone. By including both injections, we aimed to observe if any distinct biochemical changes emerge when both hormones are administered together, which would not be evident from the individual hormone injections alone. Therefore, we have retained the GH and TE injections together in Fig. 1 to reflect this comparative aspect of our study.</p><p>Comment 4: For Figs. 1, 3 and 5, the Raman spectrum for different conditions cannot be easily distinguished. Although for Fig.1 it's not that bad, however, for Figs.3 and 5, the individual spectrum/peaks are not clearly visible. It is advisable to vertically shift the individual spectrum for better clarity.</p><p>Response: We appreciate your feedback and suggestion to vertically shift the individual spectra in Figures. While we understand the concern, we believe that the current presentation of the spectra effectively conveys the necessary information, as the variations in intensity and spectral features are still distinguishable, especially in Fig. 1. For Figs. 3 and 5, the overlap of individual spectra is a result of the subtle biochemical changes we are investigating, and the vertical shift may not significantly improve the visibility of the spectral differences. We instead enhanced the figure clarity by using different line colors.</p><p>Comment 5: "The SERS spectra of blood from non-injected rats and the injected, as shown in Fig 1, are nearly identical, with a few minor band intensity variations suggesting subtle but distinct biochemical changes....". It is good to explain/justify why there is not much change/shift observed between the non-injected and injected spectra. What do the authors mean by subtle but distinct biochemical changes?</p><p>Response: We appreciate your insightful comment. To clarify this point, we have revised the text in Section 3.1.</p><p>Comment 6: The authors must try to enhance the overall readability of the paper to ensure it is accessible to a broad audience. Also, please check the reference formatting.</p><p>Response: Done as suggested.</p><supplementary-material id="pone.0323697.s002" position="float" content-type="local-data"><label>Attachment</label><caption><p>Submitted filename: <named-content content-type="submitted-filename">Reviewercomments_letter1.pdf</named-content></p></caption><media xlink:href="pone.0323697.s002.pdf"/></supplementary-material></body></sub-article><sub-article article-type="editor-report" id="pone.0323697.r004" specific-use="decision-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0323697.r004</article-id><title-group><article-title>Decision Letter 1</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tabish</surname><given-names>Tanveer</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2025 Tanveer Tabish</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Tanveer Tabish</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0323697" id="rel-obj004" related-article-type="reviewed-article"/><custom-meta-group><custom-meta><meta-name>Submission Version</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></front-stub><body><p>
<named-content content-type="letter-date">14 Apr 2025</named-content>
</p><p>Chemometrics-aided Surface-enhanced Raman spectrometric detection and quantification of GH and TE hormones in blood</p><p>PONE-D-25-09375R1</p><p>Dear Dr. Ondieki,</p><p>We&#x02019;re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p><p>Within one week, you&#x02019;ll receive an e-mail detailing the required amendments. When these have been addressed, you&#x02019;ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p><p>An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at <ext-link xlink:href="https://www.editorialmanager.com/pone/" ext-link-type="uri">Editorial Manager&#x000ae;</ext-link> &#x000a0;and clicking the &#x02018;Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.</p><p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they&#x02019;ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p><p>Kind regards,</p><p>Tanveer A. Tabish</p><p>Academic Editor</p><p>PLOS ONE</p><p>Additional Editor Comments (optional):</p><p>Reviewers' comments:</p></body></sub-article><sub-article article-type="editor-report" id="pone.0323697.r005" specific-use="acceptance-letter"><front-stub><article-id pub-id-type="doi">10.1371/journal.pone.0323697.r005</article-id><title-group><article-title>Acceptance letter</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tabish</surname><given-names>Tanveer</given-names></name><role>Academic Editor</role></contrib></contrib-group><permissions><copyright-statement>&#x000a9; 2025 Tanveer Tabish</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Tanveer Tabish</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0323697" id="rel-obj005" related-article-type="reviewed-article"/></front-stub><body><p>PONE-D-25-09375R1</p><p>PLOS ONE</p><p>Dear Dr. Ondieki,</p><p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.</p><p>At this stage, our production department will prepare your paper for publication. This includes ensuring the following:</p><p>* All references, tables, and figures are properly cited</p><p>* All relevant supporting information is included in the manuscript submission,</p><p>* There are no issues that prevent the paper from being properly typeset</p><p>You will receive further&#x000a0;instructions from the production team, including instructions on how to review your proof when it&#x000a0;is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.</p><p>Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.</p><p>If we can help with anything else, please email us at customercare@plos.org.</p><p>Thank you for submitting your work to PLOS ONE and supporting open access.</p><p>Kind regards,</p><p>PLOS ONE Editorial Office Staff</p><p>on behalf of</p><p>Dr. Tanveer A. Tabish</p><p>Academic Editor</p><p>PLOS ONE</p></body></sub-article></article>